Use of exogenous lactic bacteria strain against actinomyces naeslundii related diseases
CA 2410591 A1 · Owner: Guggenheim, Bernhard · Inventors: Neeser, Jean-Richard; Comelli, Elena-Maria; Stingele, Francesca
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
The use of a lactic bacteria strain that is exogenous to the oral microflora which has been selected for its ability to adhere the pellicle of the teeth and to produce a growth inhibition factor for the preparation of a , composition intended for reducing dental plaque and for treating or preventing root caries and other diseases related to Actinomyces naeslundii in mammals.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed May 30, 2001. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended May 30, 2021.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by May 30, 2023.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.